HUM vs NVCR · P/E 39, rev $129.66B vs rev $605.2M
Humana Inc (HUM) versus Novocure Ltd (NVCR) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Novocure Ltd (NVCR) is a medical devices company listed on US.
Latest reported HUM revenue for 2025-12-31 was $129.66B. Net income was $1.19B. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported NVCR revenue for 2024-12-31 was $605.2M. Net income was -$168.6M. Revenue was up 18.8% from 2023-12-31 to 2024-12-31. NVCR currently screens at market cap $1.99B.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. NVCR currently screens at market cap $1.99B.
Not investment advice. Open the HUM and NVCR stock pages for the full models.
Not investment advice.